Skip to main content

Not investment advice.Read full disclaimer

CLDI: Calidi Biotherapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

0thpctl

Volume

0.74×avg

Market Cap

1.29MUSD

P/E Ratio

-0.1TTM

Div Yield

-ann

Continue with finqOS

Explore Calidi Biotherapeutics, Inc.'s financials

Income statements, balance sheets, and cash flows - annual and quarterly, going back 20+ years.

Start Free Trial→Sign In

14-day free trial · No credit card required

Calidi Biotherapeutics, Inc.

CLDINew York Stock Exchange American·USD·Closed

Calidi Biotherapeutics, Inc.

CLDINew York Stock Exchange American·USD·Closed

$0.17

+0.00%

$0.17

+$0.00 (0.00%)

52W Range

0thpctl

Volume

0.74×avg

Mkt Cap

1.29MUSD

P/E

-0.1TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings